Lynx1 Capital Management LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for TScan Therapeutics, Inc. (TCRX)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: TCRX
Shares outstanding: 49.1M shares
Disclosed Ownership: 5.36M shares
Ownership: 10.9%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 09:00 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	10.9%	5.36M	0	5.36M	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	10.9%	5.36M	0	5.36M	/s/ Weston Nichols	Weston Nichols, Individually